CAS: 1454585-06-8
![N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine](https://static.cymitquimica.com/products/IN/thumb/DA00ABTA.jpg)
N-((4,5-difluoro-1H-benzo[d]imidazol-2-yl)methyl)-9-(3-fluorophenyl)-2-morpholino-9H-purin-6-amine
CAS:1454585-06-8
Formula:
C23H19F3N8O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
480.4452
Ref: IN-DA00ABTA
| 10mg | 60.00 € | ||
| 50mg | 156.00 € | ||
| 100mg | 202.00 € |
Estimated delivery in United States, on Wednesday 22 Jan 2025
SR-3029
CAS:1454585-06-8
SR-3029 is a potent and highly specific CK1δ/CK1ε inhibitor.
Formula:
C23H19F3N8O
Purity:
99.64%
Color and Shape:
Solid
Molecular weight:
480.45
Ref: TM-T3972
| 1mg | 35.00 € | ||
| 5mg | 79.00 € | ||
| 10mg | 116.00 € | ||
| 25mg | 241.00 € | ||
| 50mg | 388.00 € | ||
| 1mL*10mM (DMSO) | 84.00 € |
Estimated delivery in United States, on Wednesday 29 Jan 2025
SR 3029
CAS:1454585-06-8
SR 3029 is a small-molecule drug that has potent antitumor activity. It inhibits cancer cell …
Formula:
C23H19F3N8O
Purity:
Min. 95%
Molecular weight:
480.45 g/mol
Ref: 3D-EIC58506
| 25mg | 1,090.00 € | ||
| 50mg | 1,515.00 € | ||
| 100mg | 2,423.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
